Labial Biopsy in Patients With Tuberculosis Disease

The distinction between Tuberculosis disease (TB), a worldwide infective granulomatosis requiring long-term antibiotic treatment, and sarcoïdosis, a rare granulomatous disease successfully treated with high dose steroids is not straightforward and may delay the treatment choice by the physician.

The goal was to evaluate prospectively and consecutively the presence of epithelioid granulomas in salivary glands biopsy of patients with TB.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tuberculosis Actinomycetales Infections Bacterial Infections Bacterial Infections and Mycoses Gram-Positive Bacterial Infections Hemic and Lymphatic Diseases Hypersensitivity Hypersensitivity, Delayed Immune System Diseases Infections Lymphatic Diseases Lymphoproliferative Disorders Mycobacterium Infections Sarcoidosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Unite de Recherche Thérapeutique

Paris, 75010, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adults above 18 years,
bacteriologically confirmed tuberculosis

Exclusion criteria

patient not able to sign written consent

Treatment and study plan

labial biopsy

Other

Primary outcomes

presence of granuloma on labial biopsy

Time frame: at day zero of treatment of tuberculosis

Sponsors and collaborators

Lead sponsor

Hopital Lariboisière

Other

Registry information

Official study title

The Value of Labial Biopsy in 65 Patients With Tuberculosis Disease

Important dates

Study start: 2010
Primary completion: 2014
First posted: Apr 16, 2014
Registry last updated: Apr 16, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed